News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
PETERSON SCOTT ROBERT
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/13/2018 |
4
| PETERSON SCOTT ROBERT (Chief Scientific Officer) has filed a Form 4 on Cascadian Therapeutics, Inc.|
Txns:
| Unknown transaction of 3,639 shares
@ $0
Disposed/sold 8,334 options to buy
@ $19.92, valued at
$166k
Disposed/sold 8,334 options to buy
@ $41.52, valued at
$346k
Disposed/sold 8,334 options to buy
@ $28.44, valued at
$237k
Disposed/sold 25,000 options to buy
@ $10.44, valued at
$261k
Disposed/sold 25,000 options to buy
@ $10.56, valued at
$264k
Disposed/sold 41,667 options to buy
@ $21.06, valued at
$877.5k
Disposed/sold 54,167 options to buy
@ $6.9, valued at
$373.8k
Disposed/sold 51,200 options to buy
@ $4.64, valued at
$237.6k
Disposed/sold 65,000 options to buy
@ $3.99, valued at
$259.4k
Disposed/sold 11,300 restricted stock units
@ $0 |
|
| 02/02/2018 |
4
| PETERSON SCOTT ROBERT (Chief Scientific Officer) has filed a Form 4 on Cascadian Therapeutics, Inc.|
Txns:
| Granted 155,500 options to buy
@ $0 |
|
| 01/16/2018 |
4
| PETERSON SCOTT ROBERT (Chief Scientific Officer) has filed a Form 4 on Cascadian Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 923 shares
@ $3.92, valued at
$3.6k
Exercised 2,825 options to buy
@ $0 |
|
| 09/20/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/13/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/19/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/14/2012 |
3/A
| Form 3 - Initial statement of beneficial ownership of securities [amend] |
| 12/14/2012 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/11/2012 |
3
| PETERSON SCOTT ROBERT (Chief Scientific Officer) has filed a Form 3 on Oncothyreon Inc. |
|
|